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Abstract
OBJECTIVE: To investigate the effects on non-alco-
holic fatty liver disease (NAFLD) in rats of the decoc-
tion of Yiqihuoxue formula and the solution pre-
pared with the extracts from the individual herbal
medicines of the formula.
METHODS: The rat models of NAFLD were estab-
lished with high-fat diet (HFD) for 10 weeks. Thir-
ty-two rats were randomly divided into 4 groups:
the control group, the model group, the decoction
group and the solution group, 8 for each group.
From the 6th week, drinking water, the decoction
and the solution were intragastrically administrat-
ed accordingly to the rats for 5 weeks. The patho-
logical changes of the liver tissues were observed
with Hematoxylin and eosin staining, triglyceride
levels in liver tissues measured, serum alanine ami-
notransferase (ALT) activity measured, and serum
gastrin and motilin tested.
RESULTS: Fatty degeneration and vacuole-like
changes to various degrees occurred in hepatic
cells of the model group. Indicators for fat metabo-
lism, serum ALT activity and hepatic triglyceride lev-
el significantly increased, while serum gastrin and
motilin levels significantly decreased. Serum ALT ac-
tivity and the fatty deposition in hepatocytes were
significantly reduced. In the meantime, the expres-
sions of gastrin and motilin in the serum rose signif-
icantly in the treatment groups.
CONCLUSION: Both the decoction and the ex-
tracts-mixed solution had effect on NAFLD of pro-
tecting the liver function and reducing the fatty de-
position in liver, which might be achieved by regu-
lating the expression of gastrin and motilin.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Almost one-quarter of the adults in the world popula-
tion have excessive hepatic fat accumulation, and
non-alcoholic fatty liver disease (NAFLD) is the most
common form of chronic liver disease in many indus-
trialized countries.1 Although the pathogenesis of
NAFLD was complex, recent research confirmed that
the disorder of gastrointestinal hormone played an im-
portant role in this disease.2 Although Chinese herbal
formulas derived from Traditional Chinese Medicine
(TCM) have become an important option for the treat-
ment of fatty liver in recent years,3 the mechanism un-
derlying the effects is still incompletely understood.
The effect might be achieved through multiple path-
ways and targets. With the development of TCM,
513
JTCM |www. journaltcm. com
Chen SD et al. / Experimental Study
August 15, 2013 |Volume 33 | Issue 4 |
more and more effective components extracted from
Chinese medicines are used for the condition.4 The
medications can be obtained with two processes: one is
the decoction prepared with all the herbal medicines in
a formula by boiling them altogether; the other is the
solution prepared with the extracts from each individu-
al herbal medicines in the same formula by mixing
them altogether. In order to evaluate the pharmacologi-
cal effect on gastrointestinal hormone of Yiqihuoxue
formula, its decoction and the extracts-mixed solution
prepared with the same formula, were investigated in
rats of NAFLD induced by high fat diet (HFD).
MATERIALS ANDMETHODS
Animals
Thirty-two Sprague Dawley male rats, sanitary degree,
4 weeks, weighing (180 ± 10) g, were purchased from
Shanghai Silaike Experimental Animals Co., Ltd.
(Shanghai, China), license No: SCXK (Hu) 2007_
0005. They were raised in the experimental Animal
Center of the Medical College, Xiamen University
(Xiamen, China). The use of animals in this study was
approved by the Ethics Committee of Xiamen Universi-
ty (protocol XMULAC20120020).
Medicinals and reagents
The decoction was prepared with Yiqihuoxue formula
consisting of Zhizi (Fructus Gardeniae), Hongjingtian
(Radix et Rhizoma Rhodiolae Kirilowii), Jianghuang
(Rhizoma Curcumae Longae), Nüzhenzi (Fructus Ligus-
tri Lucidi) The dose ratio was of 1∶1∶1∶1. They were
purchased from Beijing Tong Ren Tang Health Phar-
maceutical Co. Ltd. (Xiamen, China), and were decoct-
ed and concentrated to 0.6 g/mL with TCM method.
The extracts-mixed solution consisted of the extracts of
geniposide, salidroside, curcumin, and oleanolic acid
constitute, and they were mixed with the ratio of 1∶1∶1
∶1. The extracts, purchased from Zelang Pharmaceuti-
cal Co., Ltd. (Nanjing, China), were dissolved with wa-
ter and concentrated to 0.024 g/mL. Both the decoc-
tion and the solution were kept in refrigerator. Triglyc-
erides (Cat No. 20120410) and serum alanine amino-
transferase (ALT; Cat No. 20120514) were purchased
from Beijing BHKT Clinical Reagent Co., Ltd. (Bei-
jing, China). Rat serum gastrin (Cat No. F05353) and
motilin (Cat No. F00252) ELISA kits were purchased
from R&D Co., Ltd. (Minneapolis, MN, USA).
Animals model establishment and treatment
A control group of 8 rats was randomly selected from
thirty-two rats. The rest of 24 rats were used to create
NALFD models. The models were induced by high fat
feed (HFD), which consisted of 83.25% basic feed,
10% lard, 1.5% cholesterol, 0.2% sodium deoxycho-
late, 5% sugar, 0.05% prothio-pyrimidine, while the
control group was fed with normal chow. At the 6th
week after models were established, the 24 rats were
randomly divided into 3 groups: the model group, the
decoction group, and the solution group, 8 in each
group. The rats in the decoction group and the solu-
tion group were intragastrically administered the decoc-
tion and the solution (1 mL/100 g body weight) respec-
tively, QD for 5 weeks. Rats in the model group and
the control group were given drinking water (1 mL/
100 g body weight). After the last administration was
finished, the rats fasted for 12 h on just water, then
they were weighed and anesthetized with intraperitone-
al injection of 2% pentobarbital (3 mL/kg body
weight). The abdomen was open, and blood was taken
from the inferior vena cava and centrifuged at 4℃ for
15 min at 3000 r/min. The supernatant was taken and
stored at－80℃. The liver was removed and two small
pieces in the same location of right lobe of the liver
were taken and placed into 10% neutral formaldehyde
buffer for fixation. Other liver tissues were further di-
vided into several parts, kept in centrifuge tubes and
stored at－80℃.
Measured variables and methods
Hematoxylin and eosin (HE) staining were used to
determine pathological changes of hepatic tissue. Af-
ter HE staining, the degrees of lipid degeneration of
liver cells were observed under a light microscope.
Enzyme colorimetric analysis was used for the detec-
tion of triglyceride and FFA levels in the liver tissues.
Lai's method was used for the detection of serum
ALT activity. gastrin and motilinin serum were de-
tected with ELISA.
Statistical analyses
All data were analyzed with SPSS 13.0 (SPSS Inc., Chi-
cago, IL, USA). The quantitative data were expressed
with mean±standard deviation ( xˉ ±s). One-way ANO-
VA was performed for comparison. P<0.05 was consid-
ered statistically significant.
RESULTS
Pathological changes in hepatic tissue
The photomicrographs of the HE stain showed that
HFD increased hepatic fat deposit, evidenced by the
majority of the hepatocytes of HFD rats distended by
fat in comparison to the control group (Fig-
ures 1A, 1B). The images of HE staining also displayed
macrovesicular steatosis for many single large droplets
had displaced the nucleus and ballooning degeneration
caused conspicuous swelling of the cell and cytoplas-
mic vacuolation (Figure 1B). In the decoction group
and the solution group, lipid degeneration and inflam-
matory response were significantly alleviated compared
with the model group. Liver cell volume became small-
er, hepatic lobules were clearly delineated, and the fat
droplets were reduced (Figure 1C, 1D).
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Body weight and liver weight
HFD increased body weight compared to the rats in
the control group [(378.7 ± 29.1) g vs (308.2 ± 20.2)
g], and increased liver weight by 2.2 folds compared
to normal chow fed rats [(14.4±0.6) g vs (7.5±0.5)
g]. The body weight and liver weight were signifi-
cantly lighter in the decoction group and the solu-
tion group than those in the model group (P<0.05;
Table 1).
Triglyceride level in liver tissue
As shown in Table 2, HFD significantly increased tri-
glyceride by 2.4 folds when compared with normal
chow fed rats. Both the decoction and the solution
were able to significantly inhibit the HFD-induced ele-
vation of triglyceride level [(2.7 ± 0.5) mmol/L and
(2.3 ± 0.5) mmol/L] (P<0.05) compared to the model
group (3.6±0.3) mmol/L].
Serum ALT activity in normal chow rats
Compared with the control group (19.8±7.3) U/L, se-
rum ALT activity in the model group significantly in-
creased (72.4±29.6) U/L (P<0.01), and compared with
the model group, serum ALT activities in the decoc-
tion group and the solution group significantly de-
creased [(43.6±10.3) U/L and (36.3±11.5) U/L] (P<
0.05; Table 2).
Serum gastrin and motilinin normal chow rats
Compared with the control group, serum gastrin and
motilin levels in the model group significantly de-
creased (P<0.01), and compared with the model
group, serum gastrin and motilin levels in the decoc-
tion group and the solution group significantly in-
creased (P<0.05; Table 3).
DISCUSSION
NAFLD is a condition closely related to insulin resis-
tance and metabolic syndrome, and associated with ge-
netic susceptibility. NAFLD can start from non-alco-
holic simple fatty liver (NAFL) to non-alcoholic steato-
hepatitis (NASH), and then cause cirrhosis in the liver,
and even hepatocellular carcinoma.5,6 In terms of TCM
theory, the etiology of NAFLD is poor diet or emotion-
al disorders, and the pathogenesis for the disease is the
combination of phlegm and blood stasis.7 The Yiqi-
huoxue formula has been used in clinical practice to
treat NAFLD. However, the effective components in
the formula and the underlying molecular mechanism
needs to be further investigated.
It is reported that pretreatment with salidroside, an ex-
tract of a herbal medicine used in TCM, was able to
prevent the elevation of ALT, AST and serum TNF-α,
and to decrease HIF1α immunostaining in a mouse
model of sublethal APAP toxicity compared to the un-
treated control.8 And pretreatment with oleanolic ac-
id (25 mg/kg) intramuscularly protected against hepa-
totoxicity and nephrotoxicity in rats induced by APAP
(2.5 g/kg). These results provide evidence of inhibiting
Figure 1 HE staining of the hepatic tissue in all groups (×200)
A: the control group, was fed with normal chow; B: the mod-
el group, were induced by high fat feed; C: the decoction
group, were intragastrically administered the decoction and
the solution respectively; D: the solution group, were intra-
gastrically administered the decoction and the solution re-
spectively. HE: hematoxylin and eosin.
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Table 1 Effects of decoction and solution on body weight
and liver weight ( xˉ ±s)
Group
Control
Model
Decoction
Solution
Body weight (g)
308.2±20.2
378.7±29.1a
346.3±21.5b
322.2±8.9b
Liver weight (g)
7.5±0.5
14.4±0.6a
13.1±0.8b
12.9±0.7b
Notes: the control group was fed with normal chow, and the
models were induced by high fat feed. The decoction group and
the solution group were intragastrically administered the decoc-
tion and the solution respectively. aP<0.01, compared to the con-
trol group; bP<0.05, compared to the model group.
Group
Control
Model
Decoction
Solution
TG (mmol/L)
1.5±0.1
3.6±0.3a
2.7±0.5b
2.3±0.5b
ALT (U/L)
19.8±7.3
72.4±29.6a
43.6±10.3b
36.3±11.5b
Table 2 Effects of decoction and solution on triglyceride lev-
el in liver tissue and serum ALT activity ( xˉ ±s)
Notes: the control group was fed with normal chow, and the
models were induced by high fat feed. The decoction group and
the solution group were intragastrically administered the decoc-
tion and the solution respectively. aP<0.01, compared to the con-
trol group; bP<0.05, compared to the model group.
Group
Control
Model
Decoction
Solution
GAS (ng/mL)
0.23±0.04
0.14±0.01a
0.19±0.02b
0.20±0.02b
MTL (ng/mL)
0.33±0.05
0.21±0.02a
0.28±0.03b
0.29±0.02b
Table 3 Effects of decoction and solution on serum gastrin
and motilin levels ( xˉ ±s)
Notes: the control group was fed with normal chow, and the
models were induced by high fat feed.The decoction group and
the solution group were intragastrically administered the decoc-
tion and the solution respectively. aP<0.01, compared to the con-
trol group; bP<0.05, compared to the model group.
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nitric oxide overproduction and consequently main-
taining intracellular GSH levels. This may play a pivot-
al role in the protective effects of oleanolic acid against
APAP-induced hepatic and renal injuries.9 Geniposide
(200 and 400 mg/kg) significantly decreased the blood
glucose, insulin and triglyceride levels in diabetic mice
in a dose-dependent manner. This compound also de-
creased the expression of GP and G6Pase at mRNA
and immunoreactive protein levels, as well as enzyme
activity.10 Curcumin, a member of the ginger family, is
the principal curcuminoid of the popular spice turmer-
ic utilized in Indian and other South Asia countries. Its
polyphenolic compound has anti-tumor, anti-prolifera-
tive, anti-oxidant, and anti-inflammatory properties.11
In recent study, curcumin significantly attenuated the
effect of HFD on glucose disposal, body weight/fat
gain, as well as the development of insulin resistance.
No stimulatory effect on Wnt activation was observed
in the mature fat tissue. In addition, curcumin did not
stimulate Wnt signaling in vitro in primary rat adipo-
cytes. Furthermore, curcumin inhibited lipogenic gene
expression in the liver and blocked the effects of HFD
on macrophage infiltration and the inflammatory path-
way in the adipose tissue.12 This study found that the
decoction and the solution had significant effects on
lowering triglyceride level of liver tissue in the model
group.
Recently, the role of gastrointestinal hormones in the
regulation of lipid metabolism becomes more and
more important. Gastrointestinal hormones have func-
tion to optimize the process of digestion and absorp-
tion of nutrients by the gut.13 Motilin is one of gastro-
intestinal hormones, a 22-amino-acid peptide synthe-
sized from endocrine cells of the duodeno-jejunal mu-
cosa,14 interacts directly with its receptor, induces
smooth muscle contraction and improves peristalsis in
the small intestine.15,16 Motilin regulates the interdiges-
tive migrating contractions (IMC), the fasting motor
pattern in the gastrointestinal tract.17 Motilin plasma
level increases cyclically every 90-120 min during the
interdigestive fasting period, and this cyclical release of
motilindisappears after ingestion of a meal. These cycli-
cal peaks of plasma motilinare synchronized to strong
peristaltic contractions initiated from the stomach and
migrating to the duodenum and small intestine. This
pattern of migrating waves is known as the phase III
contraction of IMC. In the present study, the serum
motilinlevel was significantly lower in model rats than
in normal rats and significantly higher after interven-
tion. It is reported that in the study of Miegueu P, mo-
tilinmay directly influence adipocyte functions by con-
trolling energy storage.18 Gastrin was subsequently
shown to be secreted from neuroendocrine G cells
which are principally located in the antrum of the
stomach. The gastrin gene is located on the long arm
of chromosome 17 and encodes a 101 amino acid poly-
peptide, preprogastrin. This gene product is subjected
to a series of post translational modifications which re-
sult in the synthesis of a number of biologically active
peptides.19 Gastrin normally regulates gastric acid secre-
tion by stimulating the proliferation of enterochromaf-
fin-like cells and the release of histamine.20,21 The study
of the effect of gastrin on sphincter of Oddi is rare. But
in the research of Saqui-Salces M, the results showed
that components of food (fat) were sensed by antral cil-
ia on endocrine cells, which modulated gastrin secre-
tion and gastric acidity.22 In our study, the level of se-
rum gastrin in the model group decreased significantly
compared with that of control group, while significant-
ly increase after intervention.
The results from this study showed that after the rats
were fed with HFD for 10 weeks, the serum ALT activ-
ity and the hepatic triglyceride level significantly in-
creased and the hepatic tissue showed pathological
changes of fat degeneration and inflammatory cell infil-
tration. This suggested that HFD could induce
NAFLD pathological changes in the rats. And it was
found that serum gastrin and motilin levels in the mod-
el group significantly decreased as compared with those
in the control group. This suggested that gastrin and
motilinhave important effects on NAFLD. After treat-
ment with the decoction and the solution, serum ALT
activity and hepatic triglyceride levels significantly de-
creased, and fat degeneration and inflammatory cell in-
filtration of hepatic tissue were improved. This suggest-
ed that the decoction and the solution had significant
effects on protecting liver from damage caused by
NAFLD. Particularly, serum gastrin and motilin levels
in the treatment groups significantly increased com-
pared with that in the model group, suggesting that the
increase of gastrin and motilin expression might be the
mechanism underpinned the effects of the decoction
and the solution on NAFLD.
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